Warning: foreach() argument must be of type array|object, bool given in /var/www/html/web/app/themes/studypress-core-theme/template-parts/header/mobile-offcanvas.php on line 20

As genetic testing becomes widespread, medical records will contain the results of such testing. Who should have access to this information? Should employers, potential employers, or insurance companies be allowed to have this information? Would you favor or oppose having the government establish and maintain a central database containing the results of individuals' genome scans?

Short Answer

Expert verified
Consider the ethical implications of granting access to employers, potential employers, insurance companies, and the government.

Step by step solution

01

Identify the stakeholders

The stakeholders in this situation include the individual undergoing genetic testing, employers, potential employers, insurance companies, and the government. Each of these stakeholders carries various weight on how the information should be used.
02

Address access for employers and potential employers

Discuss the pros and cons of allowing employers and potential employers access to an individual's genetic testing information. Consider factors such as: - Job performance and safety: If certain genetic predispositions may affect job performance or safety, it could be beneficial for employers to access this information. - Discrimination and privacy concerns: There is a risk that employers may discriminate based on genetic information, which can have ethical and legal implications.
03

Address access for insurance companies

Discuss the pros and cons of allowing insurance companies access to an individual's genetic testing information. Factors to include for each are: - Risk assessment and premium calculation: Genetic information could help insurance companies accurately assess risk and calculate premiums. - Discrimination and privacy concerns: Similar to employers, there is the risk that insurance companies may discriminate based on genetic information, resulting in denial of coverage or higher premiums.
04

Discuss government establishment and maintenance of a central database

Deliberate the advantages and disadvantages of government establishment and maintenance of a central database containing individuals' genome scans. Consider factors such as: - Potential for research and public health benefits: A central database could help researchers understand the prevalence of certain genetic conditions and develop more targeted treatments and public health initiatives. - Privacy and security concerns: Storing sensitive personal information in a central database may raise privacy concerns, particularly with the risk of unauthorized access or misuse.
05

Personal opinion

As this question may require your own opinion, evaluate the arguments for and against sharing genetic testing information with different stakeholders, and formulate an educated opinion based on your analysis. Consider the potential positive and negative consequences, as well as the ethical implications of each option.

Unlock Step-by-Step Solutions & Ace Your Exams!

  • Full Textbook Solutions

    Get detailed explanations and key concepts

  • Unlimited Al creation

    Al flashcards, explanations, exams and more...

  • Ads-free access

    To over 500 millions flashcards

  • Money-back guarantee

    We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with Vaia!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Genetic Information Privacy
In the era of rapid advancements in genetic testing, privacy of this sensitive information emerges as a paramount concern. The concept of genetic information privacy involves the right to control access and exposure of an individual's genetic data.

Imagine undergoing a genetic test that predicts future health conditions. This scenario holds potential for invaluable preventive healthcare, but also raises critical questions about who should have access to these results. Should your employer know if you're prone to certain diseases? Could such knowledge impact your career? What about insurance companies that might adjust your premiums based on this data? The heart of these concerns lies in the fear of genetic discrimination, a term referring to differential treatment based on one's genetic makeup.

From a step-by-step approach, the importance of safeguarding this information becomes evident. Deliberations reveal that while stakeholders such as employers and insurance companies may benefit from accessing such data, primarily for safety and risk assessment, the potential for misuse and discrimination casts a shadow on this accessibility. The equilibrium between benefits to public health and individual privacy rights is delicate, necessitating robust policies and regulations that ensure the confidentiality and protection of genetic information.
Genetic Discrimination
Delving deeper into the issues surrounding genetic information, the peril of genetic discrimination cannot be overlooked. It's the unfair treatment of individuals based on their genetic predisposition to certain health conditions, rather than their current health status.

Examples of such discrimination could be employers not hiring a candidate due to a perceived genetic risk that might lead to future sick leaves or decreased productivity. Similarly, insurance companies might deny coverage or inflate premiums for individuals with a genetic marker indicating higher health risks. These actions not only violate individual rights but also pose as a deterrent for people to participate in genetic testing, which can ultimately be detrimental to medical advancement and preventive healthcare.

As our step-by-step analysis in the textbook demonstrates, the pros and cons are multifaceted. While there's an argument to be made for the relevancy of genetic data in certain employment contexts, such as roles that pose a high safety risk, protective measures against discrimination must be established. Laws such as the Genetic Information Nondiscrimination Act (GINA) in the United States have been enacted to prevent such occurrences. Nonetheless, there's a continuous need for vigilance and advocacy to secure fair treatment for all individuals irrespective of their genetic profile.
Genomic Data Security
Lastly, the integrity of genomic data security is a central pillar in the discussion on genetic testing ethics. The challenge lies in protecting highly personal genetic information from breaches and unauthorized use.

Genomic data security involves safeguarding databases, especially when a government or any central body maintains comprehensive genetic records. While there are tremendous potential benefits for research and public health, vulnerabilities in security systems can lead to the misuse of sensitive information. The consequences of such breaches are far-reaching and can lead to identity theft, genetic discrimination, and a significant loss of public trust.

In our textbook's step-by-step solution, we weigh the pros and cons of a government-held central database of genome scans. The benefits of such a database for medical research are vast; however, the risks associated with it mean that data security has to be of the utmost priority. Effective security measures, regular audits, and a framework for ethical use are essential to ensure that individuals' genetic data remains confidential and is used in a manner that respects and upholds their privacy rights and trust.

One App. One Place for Learning.

All the tools & learning materials you need for study success - in one app.

Get started for free

Most popular questions from this chapter

In March 2010 Judge \(R\). Sweet ruled to invalidate Myriad Genetics' patents on the \(B R C A 1\) and \(B R C A 2\) genes. Sweet wrote that since the genes are part of the natural world, they are not patentable. Myriad Genetics also holds patents on the development of a direct-to-consumer test for the \(B R C A 1\) and \(B R C A 2\) genes. (a) Would you agree with Judge Sweet's ruling to invalidate the patenting of the \(B R C A 1\) and \(B R C A 2\) genes? If you were asked to judge the patenting of the direct-to-consumer test for the BRCA1 and BRCA2 genes, how would you rule? (b) J. Craig Venter has filed a patent application for his "firstever human made life form." This patent is designed to cover the genome of \(M\). genitalium. Would your ruling for Venter's "organism" be different from Judge Sweet's ruling on patenting of the \(B R C A 1\) and \(B R C A 2\) genes?

Dominant mutations can be categorized according to whether they increase or decrease the overall activity of a gene or gene product. Although a loss-of- function mutation (a mutation that inactivates the gene product) is usually recessive, for some genes, one dose of the normal gene product, encoded by the normal allele, is not sufficient to produce a normal phenotype. In this case, a loss-of-function mutation in the gene will be dominant, and the gene is said to be haploinsufficient. A second category of dominant mutation is the gain-of- function mutation, which results in a new activity or increased activity or expression of a gene or gene product. The gene therapy technique currently used in clinical trials involves the "addition" to somatic cells of a normal copy of a gene. In other words, a normal copy of the gene is inserted into the genome of the mutant somatic cell, but the mutated copy of the gene is not removed or replaced. Will this strategy work for either of the two aforementioned types of dominant mutations?

What limits the use of differences in restriction enzyme sites as a way of detecting point mutations in human genes?

The first attempts at gene therapy began in 1990 with the treatment of a young girl with a genetic disorder abbreviated SCID. What does SCID stand for? In the context of SCID, what does ADA stand for?

An unapproved form of gene therapy, known as enhancement gene therapy, can create considerable ethical dilemmas. Why?

See all solutions

Recommended explanations on Biology Textbooks

View all explanations

What do you think about this solution?

We value your feedback to improve our textbook solutions.

Study anywhere. Anytime. Across all devices.

Sign-up for free